HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

valylvaline (Val-Val)

RN given refers to (L)-isomer
Also Known As:
Val-Val; L-valyl-L-valine
Networked: 414 relevant articles (8 outcomes, 43 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ambite-Quesada, Silvia: 5 articles (01/2019 - 10/2011)
2. Hagen, Knut: 5 articles (06/2008 - 04/2006)
3. Skorpen, Frank: 5 articles (06/2008 - 04/2006)
4. Zwart, John-Anker: 5 articles (06/2008 - 04/2006)
5. Hankinson, Susan E: 5 articles (12/2006 - 05/2002)
6. Hunter, David J: 5 articles (12/2006 - 05/2002)
7. Pivac, Nela: 4 articles (01/2018 - 01/2011)
8. Wu, J: 4 articles (08/2016 - 04/2001)
9. Tamer, Lülüfer: 4 articles (01/2015 - 11/2004)
10. Zhan, Ping: 4 articles (12/2013 - 07/2010)

Related Diseases

1. Inflammation (Inflammations)
2. Schizophrenia (Dementia Praecox)
3. Endometrial Neoplasms (Endometrial Cancer)
03/01/2013 - "As for COMT Val158Met (rs4680) polymorphism, the heterogeneous genotype showed a decreased risk for endometrial cancer compared with the common homogenous genotype in a fixed-effect model in Asian population (Met/Val vs. Val/Val: pooled OR, 0.83; 95% CI, 0.70-0.98; P = 0.033; I = 29.2%), whereas no positive results are found in other subgroups or models. "
12/10/2013 - "In conclusion, our results suggested that the COMT Val/Val genotype might act as a potential endometrial cancer risk factor in postmenopausal women. "
02/01/2007 - "The most frequent genotype was COMT(Val/Val) (47.2%, 52/110) in control group and COMT(Val/Met) (58.3%, 77/132) in endometrial cancer group. "
04/15/2005 - "Interestingly, the relatively low frequency of Val/Val genotype in both the cancer cases and controls, in parallel with the lower incidence of endometrial cancer in Chinese, was observed when compared with those in Caucasians. "
12/10/2013 - "Although no obvious associations were detected between COMT Val158Met and endometrial cancer susceptibility in the pooled analysis, we noted significantly decreased endometrial cancer risk for Val/Met versus Val/Val, and Met/Met + Val/Met versus Val/Val genetic models in the postmenopausal female (OR = 0.795, 95%CI = 0.656-0.962, P = 0.019; and OR = 0.819, 95%CI = 0.683-0.983, P = 0.032; respectively), and similar results existed in high-quality studies (OR = 0.835, 95%CI = 0.726-0.961, P = 0.012; and OR = 0.853, 95%CI = 0.747-0.974, P = 0.019; respectively). "
4. Cognitive Dysfunction
5. Sleep Deprivation

Related Drugs and Biologics

1. methionylmethionine (Met-Met)
2. arginylproline
3. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
4. Peptides (Polypeptides)
5. leucyl-lysyl-tyrosine
6. lysylglutamic acid
7. histidylproline
8. Prodrugs
9. Dipeptides
10. Antiviral Agents (Antivirals)

Related Therapies and Procedures

1. Transcranial Direct Current Stimulation
2. Neoadjuvant Therapy
3. Therapeutics
4. Lasers (Laser)
5. Activities of Daily Living (ADL)